Literature DB >> 33438252

Proteomic analysis of human follicular fluid from polycystic ovary syndrome patients.

Young-Jin Sim1, A-Reum Ryu2,3, Mi-Young Lee2,3.   

Abstract

Comparative proteomic profiling of human follicular fluid (HFF) from polycystic ovary syndrome (PCOS) and non-PCOS patients who displayed low levels of fertility was carried out via two-dimensional gel electrophoresis (2-DE) combined with mass spectrometry. HFF, an important reproductive fluid, was used for the proteomic analysis of PCOS patients to determine the effect of PCOS on folliculogenesis. HFF was obtained from 10 women (average age, 35 years) undergoing in vitro fertilization at two hospitals. The proteins of HFF were separated using 2-DE analysis and validated by Western blot assay. Approximately 250 protein spots were separated on the 2-DE gel. Among them, the expression levels of seven proteins were found to change at least 1.5-fold in the PCOS patient group. Three protein spots, albumin, uncharacterized protein 1, and uncharacterized protein 2, were downregulated in PCOS patients. However, four protein spots, gelsolin, vitamin D binding protein, serum albumin, and complement factor B, were upregulated in PCOS patient group. These proteins may serve as a panel of potential pathological biomarkers during fertilization and oocyte development.
© 2021 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  gelsolin; human follicular fluid; polycystic ovary syndrome; proteomics; vitamin D binding protein

Mesh:

Year:  2021        PMID: 33438252     DOI: 10.1002/bab.2108

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  1 in total

1.  Proteomics and bioinformatics analysis of follicular fluid from patients with polycystic ovary syndrome.

Authors:  Wenqi Wang; Qi Jiang; Yue Niu; Qiaoqiao Ding; Xiao Yang; Yanjun Zheng; Jing Hao; Daimin Wei
Journal:  Front Mol Biosci       Date:  2022-08-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.